Final Deadline Alert

Bronstein, Gewirtz & Grossman, LLC Notifies Sotera Health Company (SHC) Investors of Class Action and Last Few Hours to Actively Participate

Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Sotera Health Company ("Sotera" or the "Company") (NASDAQ: SHC) certain of the Company’s current and former senior executives, members of the Company’s Board of Directors, Sotera’s private equity shareholders, and the underwriters of the November 20, 2020, initial public offering (“IPO”) and March 18, 2021, secondary public offering (“SPO”) of Sotera stock. The action is brought on behalf of all persons or entities that purchased or otherwise acquired Sotera common stock: (i) pursuant and/or traceable to the Company’s IPO conducted on or around November 20, 2020; (ii) pursuant and/or traceable to the Company’s SPO conducted on or around March 18, 2021; and/or (iii) between November 20, 2020 and September 19, 2022, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/shc1.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.

The complaint alleges that, throughout the Class Period, and in connection with the IPO and the SPO, Sotera made false and misleading representations concerning its emissions control systems and exposure to liability from lawsuits for the Company’s failure to limit harmful EtO emissions. The Company represented that it had “a proactive [environmental, health and safety] program and a culture of safety and quality.” In addition, Sotera stated that it employed adequate and effective safeguards to control EtO emissions. Moreover, Sotera and its executives vehemently denied allegations that the Company’s EtO emissions from its sterilization facilities caused cancer and other severe health issues in people living in the communities near those facilities.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/shc1 or you may contact Peretz Bronstein, Esq. or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Sotera you have until March 27, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230327005001/en/

The Sotera Health Company Stock at the time of publication of the news with a raise of +0,64 % to 17,43EUR on Nasdaq stock exchange (27. März 2023, 16:38 Uhr).